Annual CAPEX
$66.86 M
+$19.78 M+42.01%
31 December 2023
Summary:
Integra LifeSciences Holdings annual capital expenditures is currently $66.86 million, with the most recent change of +$19.78 million (+42.01%) on 31 December 2023. During the last 3 years, it has risen by +$2.98 million (+4.66%). IART annual CAPEX is now -50.30% below its all-time high of $134.53 million, reached on 31 December 2019.IART CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$29.65 M
-$61.00 K-0.21%
30 September 2024
Summary:
Integra LifeSciences Holdings quarterly capital expenditures is currently $29.65 million, with the most recent change of -$61.00 thousand (-0.21%) on 30 September 2024. Over the past year, it has increased by +$16.57 million (+126.69%). IART quarterly CAPEX is now -62.28% below its all-time high of $78.59 million, reached on 30 September 2019.IART Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$99.35 M
+$16.57 M+20.01%
30 September 2024
Summary:
Integra LifeSciences Holdings TTM capital expenditures is currently $99.35 million, with the most recent change of +$16.57 million (+20.01%) on 30 September 2024. Over the past year, it has increased by +$42.57 million (+74.96%). IART TTM CAPEX is now -29.02% below its all-time high of $139.97 million, reached on 31 March 2020.IART TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IART CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.0% | +126.7% | +75.0% |
| 3 y3 years | +4.7% | +306.9% | +102.7% |
| 5 y5 years | -14.0% | -62.3% | -28.0% |
IART CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +42.0% | -0.2% | +306.9% | at high | +112.7% |
| 5 y | 5 years | -50.3% | +42.0% | -62.3% | +346.9% | -29.0% | +112.7% |
| alltime | all time | -50.3% | +8258.1% | -62.3% | +310.4% | -29.0% | +970.9% |
Integra LifeSciences Holdings CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $29.65 M(-0.2%) | $99.35 M(+20.0%) |
| June 2024 | - | $29.71 M(+92.1%) | $82.78 M(+20.6%) |
| Mar 2024 | - | $15.46 M(-37.0%) | $68.63 M(+2.6%) |
| Dec 2023 | $66.86 M(+42.0%) | $24.54 M(+87.6%) | $66.86 M(+17.7%) |
| Sept 2023 | - | $13.08 M(-15.9%) | $56.79 M(+7.4%) |
| June 2023 | - | $15.55 M(+13.5%) | $52.86 M(+13.1%) |
| Mar 2023 | - | $13.70 M(-5.2%) | $46.72 M(-0.8%) |
| Dec 2022 | $47.09 M(-2.1%) | $14.46 M(+57.9%) | $47.09 M(-21.7%) |
| Sept 2022 | - | $9.15 M(-2.7%) | $60.11 M(+3.2%) |
| June 2022 | - | $9.41 M(-33.1%) | $58.24 M(+5.0%) |
| Mar 2022 | - | $14.07 M(-48.8%) | $55.47 M(+15.4%) |
| Dec 2021 | $48.08 M(-24.7%) | $27.48 M(+277.2%) | $48.08 M(-1.9%) |
| Sept 2021 | - | $7.29 M(+9.8%) | $49.02 M(+1.2%) |
| June 2021 | - | $6.63 M(-0.6%) | $48.46 M(-1.2%) |
| Mar 2021 | - | $6.67 M(-76.5%) | $49.05 M(-23.2%) |
| Dec 2020 | $63.89 M(-52.5%) | $28.43 M(+322.6%) | $63.89 M(+10.8%) |
| Sept 2020 | - | $6.73 M(-6.8%) | $57.66 M(-55.5%) |
| June 2020 | - | $7.22 M(-66.5%) | $129.52 M(-7.5%) |
| Mar 2020 | - | $21.52 M(-3.0%) | $139.97 M(+4.0%) |
| Dec 2019 | $134.53 M(+73.1%) | $22.19 M(-71.8%) | $134.53 M(-2.5%) |
| Sept 2019 | - | $78.59 M(+344.9%) | $138.02 M(+81.4%) |
| June 2019 | - | $17.66 M(+9.8%) | $76.10 M(-3.0%) |
| Mar 2019 | - | $16.09 M(-37.4%) | $78.44 M(+0.9%) |
| Dec 2018 | $77.74 M(+78.7%) | $25.68 M(+54.1%) | $77.74 M(+18.2%) |
| Sept 2018 | - | $16.67 M(-16.7%) | $65.75 M(+15.6%) |
| June 2018 | - | $20.00 M(+30.0%) | $56.88 M(+14.4%) |
| Mar 2018 | - | $15.39 M(+12.3%) | $49.70 M(+14.2%) |
| Dec 2017 | $43.50 M(-8.1%) | $13.70 M(+75.7%) | $43.50 M(-14.7%) |
| Sept 2017 | - | $7.80 M(-39.2%) | $51.00 M(+1.6%) |
| June 2017 | - | $12.82 M(+39.5%) | $50.18 M(+10.0%) |
| Mar 2017 | - | $9.19 M(-56.6%) | $45.62 M(-3.6%) |
| Dec 2016 | $47.33 M(+41.6%) | $21.19 M(+203.9%) | $47.33 M(+20.6%) |
| Sept 2016 | - | $6.97 M(-15.6%) | $39.23 M(+4.3%) |
| June 2016 | - | $8.27 M(-24.1%) | $37.62 M(-3.5%) |
| Mar 2016 | - | $10.89 M(-16.8%) | $38.98 M(+16.7%) |
| Dec 2015 | $33.41 M(-13.9%) | $13.10 M(+144.3%) | $33.41 M(+4.3%) |
| Sept 2015 | - | $5.36 M(-44.3%) | $32.02 M(-3.2%) |
| June 2015 | - | $9.62 M(+80.5%) | $33.08 M(+0.8%) |
| Mar 2015 | - | $5.33 M(-54.5%) | $32.81 M(-15.5%) |
| Dec 2014 | $38.81 M(-8.2%) | $11.71 M(+82.4%) | $38.81 M(+22.5%) |
| Sept 2014 | - | $6.42 M(-31.4%) | $31.69 M(-17.7%) |
| June 2014 | - | $9.36 M(-17.5%) | $38.52 M(-10.0%) |
| Mar 2014 | - | $11.34 M(+147.5%) | $42.78 M(+1.1%) |
| Dec 2013 | $42.30 M(-38.7%) | $4.58 M(-65.4%) | $42.30 M(-32.2%) |
| Sept 2013 | - | $13.25 M(-2.8%) | $62.39 M(-9.4%) |
| June 2013 | - | $13.62 M(+25.5%) | $68.86 M(-0.9%) |
| Mar 2013 | - | $10.85 M(-56.0%) | $69.47 M(+0.6%) |
| Dec 2012 | $69.03 M(+79.7%) | $24.67 M(+25.1%) | $69.03 M(+20.3%) |
| Sept 2012 | - | $19.72 M(+38.6%) | $57.40 M(+15.0%) |
| June 2012 | - | $14.23 M(+36.7%) | $49.93 M(+16.3%) |
| Mar 2012 | - | $10.41 M(-20.2%) | $42.91 M(+11.7%) |
| Dec 2011 | $38.42 M(+3.5%) | $13.04 M(+6.5%) | $38.42 M(-11.9%) |
| Sept 2011 | - | $12.24 M(+69.7%) | $43.62 M(+13.1%) |
| June 2011 | - | $7.22 M(+21.9%) | $38.59 M(+4.0%) |
| Mar 2011 | - | $5.92 M(-67.5%) | $37.12 M(-0.1%) |
| Dec 2010 | $37.14 M | $18.24 M(+153.1%) | $37.14 M(+23.0%) |
| Sept 2010 | - | $7.21 M(+25.4%) | $30.18 M(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | $5.75 M(-3.3%) | $30.99 M(+1.7%) |
| Mar 2010 | - | $5.94 M(-47.3%) | $30.47 M(+10.5%) |
| Dec 2009 | $27.57 M(+105.7%) | $11.29 M(+40.9%) | $27.57 M(+35.2%) |
| Sept 2009 | - | $8.01 M(+53.4%) | $20.39 M(+31.0%) |
| June 2009 | - | $5.22 M(+71.5%) | $15.57 M(+14.4%) |
| Mar 2009 | - | $3.05 M(-25.9%) | $13.60 M(+1.5%) |
| Dec 2008 | $13.40 M(-40.6%) | $4.11 M(+28.8%) | $13.40 M(-8.3%) |
| Sept 2008 | - | $3.19 M(-2.1%) | $14.62 M(-17.0%) |
| June 2008 | - | $3.26 M(+14.6%) | $17.61 M(-18.4%) |
| Mar 2008 | - | $2.84 M(-46.6%) | $21.57 M(-4.5%) |
| Dec 2007 | $22.57 M(+95.9%) | $5.33 M(-13.8%) | $22.57 M(+4.8%) |
| Sept 2007 | - | $6.18 M(-14.4%) | $21.53 M(+13.5%) |
| June 2007 | - | $7.22 M(+87.5%) | $18.97 M(+38.6%) |
| Mar 2007 | - | $3.85 M(-10.2%) | $13.68 M(+18.8%) |
| Dec 2006 | $11.52 M(+43.1%) | $4.28 M(+18.4%) | $11.52 M(+33.1%) |
| Sept 2006 | - | $3.62 M(+87.4%) | $8.66 M(+26.4%) |
| June 2006 | - | $1.93 M(+14.3%) | $6.85 M(-1.6%) |
| Mar 2006 | - | $1.69 M(+18.9%) | $6.96 M(-13.6%) |
| Dec 2005 | $8.05 M(-5.3%) | $1.42 M(-21.4%) | $8.05 M(-14.7%) |
| Sept 2005 | - | $1.81 M(-11.6%) | $9.44 M(+10.8%) |
| June 2005 | - | $2.04 M(-26.5%) | $8.52 M(+1.3%) |
| Mar 2005 | - | $2.78 M(-1.1%) | $8.41 M(-1.1%) |
| Dec 2004 | $8.51 M(+121.4%) | $2.81 M(+218.0%) | $8.51 M(+18.6%) |
| Sept 2004 | - | $884.00 K(-54.4%) | $7.17 M(-0.5%) |
| June 2004 | - | $1.94 M(-32.6%) | $7.21 M(+16.7%) |
| Mar 2004 | - | $2.88 M(+94.7%) | $6.18 M(+60.7%) |
| Dec 2003 | $3.84 M(+70.5%) | $1.48 M(+61.1%) | $3.84 M(+29.2%) |
| Sept 2003 | - | $917.00 K(+1.1%) | $2.97 M(+14.4%) |
| June 2003 | - | $907.00 K(+67.3%) | $2.60 M(+20.0%) |
| Mar 2003 | - | $542.00 K(-10.9%) | $2.17 M(-3.9%) |
| Dec 2002 | $2.25 M(-21.2%) | $608.00 K(+12.0%) | $2.25 M(-11.6%) |
| Sept 2002 | - | $543.00 K(+14.8%) | $2.55 M(-8.8%) |
| June 2002 | - | $473.00 K(-24.9%) | $2.79 M(-9.7%) |
| Mar 2002 | - | $630.00 K(-30.2%) | $3.09 M(+8.2%) |
| Dec 2001 | $2.86 M(-12.5%) | $903.00 K(+14.4%) | $2.86 M(+12.5%) |
| Sept 2001 | - | $789.00 K(+2.2%) | $2.54 M(+14.9%) |
| June 2001 | - | $772.00 K(+94.9%) | $2.21 M(-4.3%) |
| Mar 2001 | - | $396.00 K(-32.3%) | $2.31 M(-29.2%) |
| Dec 2000 | $3.27 M(+41.5%) | $585.00 K(+27.2%) | $3.27 M(-128.6%) |
| Sept 2000 | - | $460.00 K(-47.2%) | -$11.41 M(+9.0%) |
| June 2000 | - | $872.00 K(-35.5%) | -$10.47 M(-1.6%) |
| Mar 2000 | - | $1.35 M(-109.6%) | -$10.64 M(-560.8%) |
| Dec 1999 | $2.31 M(+98.0%) | -$14.09 M(-1106.5%) | $2.31 M(-86.1%) |
| Sept 1999 | - | $1.40 M(+100.0%) | $16.67 M(+7.1%) |
| June 1999 | - | $700.00 K(-95.1%) | $15.57 M(+2.6%) |
| Mar 1999 | - | $14.30 M(+5275.9%) | $15.17 M(+1200.7%) |
| Dec 1998 | $1.17 M(+45.8%) | $266.00 K(-11.3%) | $1.17 M(-2.8%) |
| Sept 1998 | - | $300.00 K(0.0%) | $1.20 M(0.0%) |
| June 1998 | - | $300.00 K(0.0%) | $1.20 M(+9.1%) |
| Mar 1998 | - | $300.00 K(0.0%) | $1.10 M(+37.5%) |
| Dec 1997 | $800.00 K(-33.3%) | $300.00 K(0.0%) | $800.00 K(-109.8%) |
| Sept 1997 | - | $300.00 K(+50.0%) | -$8.20 M(-1271.4%) |
| June 1997 | - | $200.00 K(-102.3%) | $700.00 K(-41.7%) |
| Dec 1996 | $1.20 M(-58.6%) | -$8.70 M(-194.6%) | $1.20 M(-87.9%) |
| Sept 1996 | - | $9.20 M(+2200.0%) | $9.90 M(+1314.3%) |
| June 1996 | - | $400.00 K(+33.3%) | $700.00 K(+133.3%) |
| Mar 1996 | - | $300.00 K | $300.00 K |
| Dec 1995 | $2.90 M | - | - |
FAQ
- What is Integra LifeSciences Holdings annual capital expenditures?
- What is the all time high annual CAPEX for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings annual CAPEX year-on-year change?
- What is Integra LifeSciences Holdings quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings quarterly CAPEX year-on-year change?
- What is Integra LifeSciences Holdings TTM capital expenditures?
- What is the all time high TTM CAPEX for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings TTM CAPEX year-on-year change?
What is Integra LifeSciences Holdings annual capital expenditures?
The current annual CAPEX of IART is $66.86 M
What is the all time high annual CAPEX for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high annual capital expenditures is $134.53 M
What is Integra LifeSciences Holdings annual CAPEX year-on-year change?
Over the past year, IART annual capital expenditures has changed by +$19.78 M (+42.01%)
What is Integra LifeSciences Holdings quarterly capital expenditures?
The current quarterly CAPEX of IART is $29.65 M
What is the all time high quarterly CAPEX for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high quarterly capital expenditures is $78.59 M
What is Integra LifeSciences Holdings quarterly CAPEX year-on-year change?
Over the past year, IART quarterly capital expenditures has changed by +$16.57 M (+126.69%)
What is Integra LifeSciences Holdings TTM capital expenditures?
The current TTM CAPEX of IART is $99.35 M
What is the all time high TTM CAPEX for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high TTM capital expenditures is $139.97 M
What is Integra LifeSciences Holdings TTM CAPEX year-on-year change?
Over the past year, IART TTM capital expenditures has changed by +$42.57 M (+74.96%)